Is the ‘Quad-demic’ the worst holiday gift ever for America? As four viruses surge across the US, here's what you need to know.

Neumora's depression drug fails Phase 3, Pfizer exits Sangamo hemophilia A gene therapy partnership, and biotech sees surge in megarounds with 96 nine-figure financings in 2024.

The president-elect has boasted about the donations for his inauguration, library and political activities from those seeking ...

Four MIT faculty members are among 23 world-class researchers who have been awarded the nation's highest honors for scientists and innovators, the ...

Thai authorities are seizing assets of Boon Vanasin, an 86-year-old doctor, who allegedly defrauded investors of over $350 ...

The U.S. continues to charge significantly higher prices for prescription drugs compared to similarly wealthy countries.

Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers ...

Another $50,000 from tobacco giant Altria last month brings money raised to expand the Republican Party of Kentucky ...

Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this month.

Kansas Reflector published plenty of important stories in 2024 — investigations into Wichita State University president ...

Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 ...

This is old news, the FDA-spinned student research is late by over a year. Other independent scientists and labs had made this discovery.